Enabling industry players to adopt biomanufacturing
The potential of biomanufacturing is clear —but scale has been the bottleneck. Curve exists to close that gap.
At Curve we combine expertise in engineering, biology and biochemistry to create robust, modular production systems for precision fermentation and cell cultivation. From food and health to chemicals and sustainable materials. Our technology bridges the gap between basic food-grade fermenters and costly pharma-grade bioreactors, with the goal to enable scale for resilient, efficient, and commercially viable biomanufacturing.
Bending the curve for a resilient tomorrow
The growing global need for affordable, safe, and sustainable protein goes far beyond food. Proteins fuel breakthroughs in healthcare, materials, nutrition, animal feed, and more. But current ways of making them rely on outdated systems that strain resources and limit innovation.
New technology is essential to deliver the proteins our world needs — at scale and with minimal impact. Smarter protein production can unlock healthier living, greener industries, and a more resilient future for all.
Designed for cost leadership
Traditional bioreactors are designed for pharma — not for the cost dynamics of lower margin markets such as food, cosmetics, and functional ingredients. Our technology changes that.
BIOBRIC is designed to reduce OPEX & CAPEX up to 70%. The technology is engineered for bioprocess flexibility and continuous optimization, combining physical hardware with data simulations to enable optimized conditions, strain learning, and automated process refinement — improving yield, stability, and cost-efficiency at every run.
BIOBRIC supports:
- Scalable biotech
- Strain and media optimization
- Real-time data insights
- Modular deployment and integration
- Simulations for predictive process optimization
Micro-organism host
Yeast / Bacteria / Fungi / Mammalian cells
BIOBRIC supports a wide range of hosts, from microbial workhorses to advanced cell systems. Designed for adaptability, it ensures stable growth, efficient nutrient use, and scalable performance — from pilot to full production.
Biotechnology
Strain optimization / Precision fermentation / Cell cultivation
Whether optimizing a new strain or scaling a precision fermentation process, BIOBRIC bridges R&D and industrial production. Our modular hardware and simulation tools simplify experimentation, accelerate learning cycles, and enable predictable scale-up.
Bio-identical ingredients
Proteins / Lipids / Sugars / Pigments / Collagen & more
Unlock the next generation of sustainable ingredients — identical to nature yet built for industry. From food and materials to beauty and health, BIOBRIC makes biomanufacturing of complex molecules commercially viable.
Efficency
Want to start biomanufacturing?
Scaling biomanufacturing shouldn’t require pharma-level budgets. The modular BIOBRIC system and our flexible business models decrease the need for large upfront investment, allowing you as our client to grow as results – not costs – increase.
We offer pre-validated systems including:
- Turnkey platforms combining hardware, strains, and media — with 50–70% lower CapEx than legacy systems.
- High-yield processes optimized for food- grade production.
- End-to-end support for onboarding, tech transfer, and continuous optimization.
Partnering for the long run
Scaling biomanufacturing is not a solo act — it’s a collaboration between innovators, engineers, and operators. Curve exists to make that collaboration seamless.
We work alongside pioneering precision fermentation companies — running joint upscaling trials that refine strains, media, and processes using BIOBRIC. Each iteration strengthens performance and economics, laying the groundwork for commercial manufacturing. Once optimized, complete validated setups are licensed to our clients who are established producers ready to scale production. This model reduces technical risk, accelerates market entry, and makes advanced biotech accessible to industries worldwide.
At Curve, collaboration isn’t a side project — it’s the engine of progress.
Enabling a new era of sustainable biotech
Curve is a biotechnology company based in Sweden creating the next generation of production systems that learns, adapts, and performs. Our mission: to unlock scalable biomanufacturing of proteins for the industries shaping tomorrow. We believe the future isn’t built in labs — it’s scaled through technology.
Scaling biotech is the next industrial revolution — but it demands tools built for this century, not the last. At Curve, we’re developing intelligent systems that unlock the potential to make biomanufacturing commercially scalable.
Jacob Schaldemose Peterson,
Co-founder & CEO, Curve
